Home Compare ACLN.SW vs NBIX
Stock Comparison · Structural lead, mixed market

Accelleron Industries vs Neurocrine Biosciences: Which Stock Looks Stronger in 2026?

Accelleron Industries holds the cleaner structural position, with profitability as the main driver and valuation adding further support. Neurocrine Biosciences still has the edge on valuation, which keeps the comparison from looking entirely one-sided. On the market side, Accelleron Industries is in better shape — its trend is intact while Neurocrine Biosciences's trend has broken down. That puts structure and market broadly in agreement — Accelleron Industries's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The result is anchored in profitability, but stability also reinforces the same direction. Accelleron Industries AG leads by 11 points on the overall comparison score.

Trajectory Similarity
0.70
Similar
Peer-set rank: #17
within Accelleron Industries AG's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

The clearest structural overlap shows up in recent revenue growth and capital structure.

Similarity drivers
recent revenue growthcapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
ACLN.SW
Accelleron Industries AG
67
Peer-Score
Signal qualityHigh
vs
NBIX
Neurocrine Biosciences, Inc.
56
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: ACLN.SW vs NBIX Profitability 81 32 Stability 70 47 Valuation 36 63 Growth 90 88 ACLN.SW NBIX
Gap Ranking
#1 Profitability +49
#2 Valuation +27
#3 Stability +23
#4 Growth +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ACLN.SW and NBIX Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ACLN.SWNBIX Relative valuation Structural strength

Accelleron Industries AG still looks stronger overall, though current pricing looks more supportive for Neurocrine Biosciences, Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, Accelleron Industries AG ranks near the top of the group; Neurocrine Biosciences, Inc. sits in the weaker half.
Valuation
On valuation, Neurocrine Biosciences, Inc. is positioned higher in the group, while Accelleron Industries AG is closer to the middle.
Profitability — Dominant Gap
ACLN.SW
81
NBIX
32
Gap+49in favour of ACLN.SW

Capital efficiency adds support, with a 20.5-point ROIC advantage.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Neurocrine Biosciences, with a forward P/E that is 14.5 turns lower there.

What this means for the comparison

The profitability lead is clear, but pricing and valuation still pull in the other direction — the result holds, but not without friction.

Explore full peer positioning in AssetNext

Break down the ACLN.SW vs NBIX comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how ACLN.SW and NBIX each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.